References
- An Y, Furber KL, Ji S. Pseudogenes regulate parental gene expression via ceRNA network. J Cell Mol Med. 2017;21(1):185–192.
- Poliseno L. Pseudogenes: newly discovered players in human cancer. Sci Signal. 2012;5(242):re5.
- Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010;465(7301):1033–1038.
- Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101–108.
- Kim MS, Pinto SM, Getnet D, et al. A draft map of the human proteome. Nature. 2014;509(7502):575–581.
- Groen JN, Capraro D, Morris KV. The emerging role of pseudogene expressed non-coding RNAs in cellular functions. Int J Biochem Cell Biol. 2014;54:350–355.
- Milligan MJ, Lipovich L. Pseudogene-derived lncRNAs: emerging regulators of gene expression. Front Genet. 2014;5:476.
- Iyer MK, Niknafs YS, Malik R, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47(3):199–208.
- Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–358.
- Welch JD, Baran-Gale J, Perou CM, et al. Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential. BMC Genomics. 2015;16:113.
- Karreth FA, Reschke M, Ruocco A, et al. The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell. 2015;161(2):319–332.
- Lin JD, Fu SS, Chen JY, et al. Clinical manifestations and gene expression in patients with conventional papillary thyroid carcinoma carrying the BRAF(V600E) mutation and BRAF pseudogene. Thyroid. 2016;26(5):691–704.
- Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer. 2007;7(12):899–910.
- De Martino M, Fusco A, Esposito F. HMGA and cancer: a review on patent literatures. Recent Pat Anticancer Drug Discov. 2019;14(3):258–267.
- Esposito F, De Martino M, Petti MG, et al. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs. Oncotarget. 2014;5(18):8341–8354.
- Esposito F, De Martino M, Forzati F, et al. HMGA1-pseudogene overexpression contributes to cancer progression. Cell Cycle. 2014;13(23):3636–3639.
- De Martino M, Palma G, Azzariti A, et al. The HMGA1 pseudogene 7 Induces miR-483 and miR-675 upregulation by activating Egr1 through a ceRNA mechanism. Genes (Basel). 2017;8:11.
- Tian X, Song J, Zhang X, et al. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2. Cell Death Dis. 2020;11(3):167.
- De Martino M, Forzati F, Marfella M, et al. HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism. Sci Rep. 2016;6:37622.
- Palumbo Junior A, de Sousa VPL, Esposito F, et al. Overexpression of HMGA1 figures as a potential prognostic factor in endometrioid endometrial carcinoma (EEC). Genes (Basel). 2019;10(5):372.
- Esposito F, De Martino M, D’Angelo D, et al. HMGA1-pseudogene expression is induced in human pituitary tumors. Cell Cycle. 2015;14(9):1471–1475.
- Palumbo A Jr., De Martino M, Esposito F, et al. HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas. Histopathology. 2018;72(7):1102–1114.
- De Biase D, Esposito F, De Martino M, et al. Characterization of inflammatory infiltrate of ulcerative dermatitis in C57BL/6NCrl-Tg(HMGA1P6)1Pg mice. Lab Anim. 2018;23677218815718. DOI:10.1177/0023677218815718
- De Martino M, De Biase D, Forzati F, et al. HMGA1-pseudogene7 transgenic mice develop B cell lymphomas. Sci Rep. 2020;10(1):7057.
- Lue JK, Amengual JE. Emerging EZH2 inhibitors and their application in lymphoma. Curr Hematol Malig Rep. 2018;13(5):369–382.
- De Martino M, Forzati F, Arra C, et al. HMGA1-pseudogenes and cancer. Oncotarget. 2016;7(19):28724–28735.